<div id="readability-page-1"><div> <div> , /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde &amp; Associates PC (the &#34;M&amp;A Class Action Firm&#34;), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating <ul type="disc"> <li> Anywhere Real Estate Inc. (NYSE: HOUS) related to its sale to Compass Inc. Under the terms of the proposed transaction, Anywhere shareholders will receive 1.436 shares of Compass Class A common stock per share of Anywhere common stock. Upon completion of the proposed transaction, current Anywhere shareholders will own approximately 22% of the combined company.</li> </ul> Click here for more information https://monteverdelaw.com/case/anywhere-real-estate-inc/. It is free and there is no cost or obligation to you. <ul type="disc"> <li> Cartica Acquisition Corp. (OTCMKTS: CRTAF) related to its merger with Nidar Infrastructure Ltd., in which the pre-transaction equity value of Nidar implied by the proposed transaction's terms is approximately $2.75 billion.</li> </ul> ACT NOW. The Shareholder Vote is scheduled for November 28, 2025. Click here for more information https://monteverdelaw.com/case/cartica-acquisition-corp/ . It is free and there is no cost or obligation to you. <ul type="disc"> <li> Berry Corporation (NASDAQ: BRY) related to its sale to California Resources Corporation. Under the terms of the proposed transaction, Berry shareholders will have their shares converted into 0.0718 shares of California Resources common stock.</li> </ul> ACT NOW. The Shareholder Vote is scheduled for December 15, 2025. Click here for more information https://monteverdelaw.com/case/berry-corporation/ https://monteverdelaw.com/case/waters-corporation/ https://monteverdelaw.com/case/guaranty-bancshares-inc/ . It is free and there is no cost or obligation to you. <ul type="disc"> <li> Akero Therapeutics, Inc. (NASDAQ: AKRO) related to its sale to Novo Nordisk A/S. Under the terms of the proposed transaction, Akero shareholders will receive $54.00 per share in cash, and a non-transferable contingent value right entitling its holder to receive a cash payment of $6.00 per share upon full U.S. regulatory approval of efruxifermin by June 30, 2031.</li> </ul> Click here for more info https://monteverdelaw.com/case/akero-therapeutics-inc/ https://monteverdelaw.com/case/sketchers-u-s-a-inc/ https://monteverdelaw.com/case/aimei-health-technology-co-ltd/ https://monteverdelaw.com/case/gms-inc/ . It is free and there is no cost or obligation to you. NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask: <ol type="1"> <li>Do you file class actions and go to Court?</li> <li>When was the last time you recovered money for shareholders?</li> <li>What cases did you recover money in and how much?</li> </ol> About Monteverde &amp; Associates PC Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341. Contact: Juan Monteverde, Esq. MONTEVERDE &amp; ASSOCIATES PC The Empire State Building 350 Fifth Ave. Suite 4740 New York, NY 10118 United States of America [email protected] Tel: (212) 971-1341 Attorney Advertising. (C) 2025 Monteverde &amp; Associates PC. The law firm responsible for this advertisement is Monteverde &amp; Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter. SOURCE Monteverde &amp; Associates PC <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTE3Jk5ld3NJdGVtSWQ9REMyNjQ1MSZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTcyMDMwUFJfTkVXU19VU1BSX19fX19EQzI2NDUx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTE3Jk5ld3NJdGVtSWQ9REMyNjQ1MSZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTcyMDMwUFJfTkVXU19VU1BSX19fX19EQzI2NDUx"/></div> </div></div>

AKRO

CITEU

CITE

Monteverde & Associates PC, a top class action firm, is investigating several mergers: Anywhere Real Estate's sale to Compass Inc., Cartica Acquisition's merger with Nidar Infrastructure, Berry Corporation's sale to California Resources, and Akero Therapeutics' sale to Novo Nordisk. The firm, known for recovering millions for shareholders, is urging shareholders to act before upcoming votes. The investigations focus on ensuring fair shareholder treatment in these transactions.

prnewswire

Berry

Akero Therapeutics

Cartica Acq - Unit

California Resources

Cartica Acquisition

20:30 ET
			
			
				SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-HOUS, CRTAF, BRY, and AKRO

20:30 ET SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-HOUS, CRTAF, BRY, and AKRO